Cyfuse Biomedical KK: Notice regarding participation in the AMED public offering project “Regeneration/Cell Medicine/Gene Therapy Realization Acceleration Program”

JPX · May 15, 2023 17:20

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.